Chambers and Partners Releases Pharmaceutical Advertising 2018 Guide
Chambers and Partners released its first ever Pharmaceutical Advertising 2018 guide, authored by Proskauer partners Lawrence Weinstein and Alexander Kaplan with assistance from several litigation...
View ArticleAnother Court Gets on (Hover) Board with Online Marketplace Liability for...
In two prior blog posts, we covered how online marketplaces, like Amazon, are being held responsible for defective and counterfeit products sold on their platforms. In the latest development in this...
View ArticleConduct Over Confusion: Supreme Court Holds Lanham Act to the Presumption...
In April, we discussed oral arguments at the Supreme Court for Abitron Austria GmbH et al. v. Hetronic International, Inc., a case in which the Supreme Court considered the extraterritorial reach of...
View ArticleFake it Until You Pay For It: The FTC Proposes New Rule Banning Fake Reviews...
At the end of June 2023, the FTC proposed a new rule targeted at deceptive reviews in the marketplace. The proposed rule would prohibit advertisers and marketers from employing illicit review and...
View ArticleFactors in Fee-Shifting for Prevailing Defendants
Statutes permitting discretionary attorney fee-shifting for prevailing defendants vary in the circumstances under which fee-shifting is permitted. Two recent cases tackling the question of why and when...
View ArticleFTC Appears to Expand AI Regulatory Role into Copyright Matters
In a recent public comment addressed to the United States Copyright Office, the Federal Trade Commission seemingly expanded upon remarks made at the National Advertising Division back in September that...
View Article
